In the TIMER2.0 database, we examined the expression of SKA1 in 38 cancer types and discovered that SKA1 was substantially differentially expressed in the tumor group in numerous malignant tumor forms, including HCC (P < .001; Fig. 2A and B). This evidence concerns the gene SKA1 and neoplasm.